Piergiorgio Messa

Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors.

Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance.

Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center.

The long-term prognosis of renal transplantation in patients with lupus nephritis.

Natural history of hepatitis B and C in renal allograft recipients.

Efficacy prospective study of different frequencies of Epo administration by i.v. and s.c. routes in renal replacement therapy patients.

Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study.

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.

Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.

Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.

Meta-analysis of biochemical and patient-level effects of calcimimetic therapy.

Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.

Therapy of secondary hyperparathyroidism to date: vitamin D analogs, calcimimetics or both?

Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature.

Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine.

How a skillful (correction of skilful) and motivated urinary sediment examination can save the kidneys.

The long-term outcome of 93 patients with proliferative lupus nephritis.

Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients.

Hepatitis C virus infection and the dialysis patient.

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.

Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy.

Hepatitis B virus infection and the dialysis patient.

Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome.

Impact of Ca/P disorders on risks and comorbidities.

Coming back to dialysis after kidney transplant failure.

Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients.

Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.

Cinacalcet: pharmacological and clinical aspects.

Calcium and phosphate control by dialysis treatments.

Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.

Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.

HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.

Current status of renal transplantation from HCV-positive donors.

Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.

Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis.

Health-related quality of life in dialysis patients with HCV infection.

Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.

[Clinical impact of hypercalcemia after kidney transplant].

An Italian external quality assessment (EQA) program on urinary sediment.

Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.

Urinary balantidiasis: diagnosis at a glance by urine sediment examination.

Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases.

Hepatic disorders in chronic kidney disease.

Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN).

Carotid plaques in patients with long-term lupus nephritis.

Therapy with nucleos(t)ide analogues: current role in dialysis patients.

Chronic kidney disease after liver transplantation: Recent evidence.

Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy.

Calcium and phosphate changes after renal transplantation.

Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey.

Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies.

Clinical utilization of cinacalcet in hypercalcemic conditions.

Membranoproliferative glomerulonephritis type I in renal transplantation patients: a single-center study of a cohort of 68 renal transplants followed up for 11 years.

Recent insights into vitamin D and its receptor.

New insights into the role of calcium-sensing receptor activation.

Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality.

Nephrin expression in adult rodent central nervous system and its interaction with glutamate receptors.

Clinical impact of hypercalcemia in kidney transplant.

[Synaptic-like signals at the filtration barrier: the role of nephrin].

Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney Disease.

HBV-related liver disease in renal insufficiency: successful antiviral therapy with entecavir.

Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients.

Hepatitis B virus vaccine in chronic kidney disease: Improved immunogenicity by adjuvants? A meta-analysis of randomized trials.

Hepatitis C-related liver disease in dialysis patients.

Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.

Hepatitis C virus infection and kidney disease: a meta-analysis.

Proteinuria and glomerular damage in Rab3A knockout mice chronically fed a high-glucose diet.

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.

Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study.

Acute interstitial nephritis after amoxycillin with hematuria, red blood cell casts and hematuria-induced acute tubular injury.

Calcimimetics in peritoneal dialysis patients.

Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study.

Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.

The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.

Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?

The evidence-based epidemiology of HCV-associated kidney disease.

The ups and downs of dialysate calcium concentration in haemodialysis patients.

Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

Fifteen years of research on nephrin: what we still need to know.

The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.

Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature review.

Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.

Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.

Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation.

Hepatitis C treatment in patients with kidney disease.

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Telaprevir in a patient with chronic hepatitis C and Cryoglobulinemic Glomerulonephritis.

Kinetics of Hepatitis B virus load during haemodialysis sessions and α-interferon: a prospective study.

Vitamin D and the cardiovascular system: an overview of the recent literature.

What happens after complete withdrawal of therapy in patients with lupus nephritis.

Hepcidin levels in chronic hemodialysis patients: a critical evaluation.

Current indications to parathyroidectomy in CKD patients before and after renal transplantation.

De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Hepatorenal syndrome and novel advances in its management.

Should Dialysate Calcium be Individualized?

[What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results].

[Control of HCV, HBV and HIV Infections in Hemodialysis].

Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.

Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature review.

Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies.

Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.

The sclerosing glomerulus in mice and man: novel insights.

FGF23 and vascular calcifications: another piece of the puzzle?

The impact of recurrence of primary glomerulonephritis on renal allograft outcome.

Update to hepatitis C review.

Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo: α-Enolase and Annexin AI.